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Abstract. Antibodies to a set of structurally related
autoantigens (p23-25) bind to a previously uncharac-
terized, large structural domain in the nucleus of a va-
riety of human cell types. This subnuclear domain is
visible by phase contrast alone as a region of decreased
density after several different fixation protocols. The
morphology of this region changes dramatically during
the cell cycle and we have given it the name PIKA
(for polymorphic interphase karyosomal association)
based on preliminary evidence that the PIKA proteins
may be associated with chromatin. The function of the
PIKA is not yet known, but our immunolocalization
B
EYOND such obvious features as the nucleolus, hetero-
chromatin, and the nuclear membrane, the structural
organization of the nucleus is surprisingly poorly un-
derstood. While many aspects of nuclear physiology have
proven amenable to analysis in vitro, a complete understand-
ing of the cellular control of nuclear processes, which in-
clude transcription, nascent RNA splicing and processing,
and transport of mature mRNA, may ultimately depend on
our knowledge of the organization of the nucleoplasmic ma-
terial surrounding the interphase chromosomes. At present,
much aboutthe organization ofthe nucleoplasm remains un-
clear. Specifically, it is unknown to what extent the nucleo-
plasm is functionally and structurally partitioned into sep-
arate domains.
Efforts to understand the structure of the nucleoplasm by
biochemical fractionation have met with only limited suc-
cess. Many attempts at separating the nucleus into its constit-
uent substructures have involved disruptive procedures such
as nuclease digestion and/or detergent and salt extraction
(Berezney and Coffey, 1975; Berezney, 1984; Vogelstein et
al ., 1985) . Biochemical fractionation procedures have per-
mitted identification of proteins associated with small nu-
clear RNA (snRNA)' (Lerner and Steitz, 1979; Pettersson
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data indicate that it is unlikely to be associated with
regions of ongoing DNA replication, heterogeneous
nuclear RNA storage, or mRNA processing. The dis-
covery of the PIKA provides evidence supporting an
emerging model of nuclear structure. It now appears
that the nucleus is organized into distinct domains
which include not only the nucleolus, but also previ-
ously unidentified regions such as the PIKAs. Further-
more, structural rearrangements undergone by the nu-
cleolus and the PIKAs may be indicative of a broad
tendency for nuclear organization to change in a cell
cycle-specific fashion.
et al., 1984; Yang et al., 1981), heterogeneous nuclear RNA
(hnRNA) (Long et al., 1979; vanEekelen and van Venrooij,
1981; Dreyfuss, 1986), and, to some extent, those associated
with newly synthesized DNA (Pardoll et al., 1980; Vogel-
stein et al., 1980; Berezney, 1984) and with the bases of
putative chromosomal loop domains (Mirkovitch et al .,
1984; Adachi et al., 1989) . However, the use of extractive
procedures for analysis of the higher-order substructure of
the nucleus has remained controversial (Mirkovitch et al .,
1984; Lothstein et al., 1985 ; Cook, 1988).
An alternative method of studying basic nuclear structure
is the use of antibodies to study the distribution of various
proteins in situ. Autoantibodies from patients with autoim-
mune diseases have been useful in the analysis of the distri-
bution of small nuclear ribonucleoproteins (snRNPs) (Ler-
ner et al., 1981; Spector, 1990) and centromeres (Moroi et
al., 1980; Cooke et al., 1990). Other autoantibodies have re-
cently been used to describe a novel "nuclear dot" domain
within the nuclei of proliferating cells (Ascoli and Maul,
1991) . In the present study, we use a new experimental an-
tiserum to describe a group ofantigens with a novel and dy-
namic nuclear distribution.
This antiserum, which recognizes a family of three or four
structurally related nuclear proteins 23-25 kD in size, iden-
tifies large, previously undescribed compartments of the nu-
cleoplasm that are visible both after staining with specific
antibody and by phase-contrast microscopy. We have termed
this newly identified constellation of subnuclear regions the
PIKA (for polymorphic interphase karyosomal association).
These results support the notion that the nucleoplasm is to
some extent organized into distinct domains. As discussed
919below, this putative structural compartmentalization may
reflect a functional segregation within the nucleus as well.
Materials and Methods
Immunological Reagents
The autoimmune patients' sera were provided through the generosity of
Naomi Rothfield (University of Connecticut, Farmington, CT) and have
been characterized in detail elsewhere (Earnshaw and Rothfield, 1985).
Purified anti-PCNA IgG was provided courtesy of Sabina Hildebrandt
(University of Connecticut) and Naomi Rothfield. The anti-Sm Y12 mono-
clonal antibody was provided courtesy ofJoan Steitz (Yale University, New
Haven, CT) and Joe Gall (Carnegie Institution, Baltimore, MD). The anti-
hnRNP protein antibodies were a gift from S. Pinol-Roma and G. Dreyfuss
(University of Pennsylvania, Philadelphia, PA). The anti-DNA antibody
was a gift of David Stollar (Tufts University, Boston, MA).
Cell Lines and Culture Techniques
HeLa cells were grown in RPMI-1640 (Gibco Laboratories, Grand Island,
NY) supplemented with 5% HyClone calf serum (HyClone Sterile Sys-
tems, Logan, UT). Primary umbilical cord fibroblasts and primary foreskin
fibroblasts were gifts ofGail Stetten (Johns Hopkins Medical School, Balti-
more, MD). K-562 cells were provided by J. Roberts (Hutchinson Cancer
Center, Seattle, WA).
Preparation ofCrude Nuclear Extract
Nuclear proteins were isolated from HeLa cells grown in suspension and
swollen in RSB (10 mM Tris-HCI, pH 7.4, 10 mM NaCl, 5 MM MgCI2)
at room temperature for 5 min. The cells were then lysed at 4°C in 15 mM
Tris-HCl, pH 7.4, 80 mM KCI, 2 mM K-EDTA, pH 7.4, 0.75 mM Spermi-
dine, 0.30 mM Spermine. Lysis was accomplished with 10 vigorous strokes
with a type A pestle in a 15-ml Dounce homogenizer (Wheaton Scientific,
Millville, NJ). The homogenate was centrifuged at 100 g for 15 min and
the pellet containing nuclei resuspended in 1% SDS protein sample buffer.
Immunoblotting
The immunoblotting procedure has been described previously (Earnshaw
et al ., 1984).
Immunofiuorescence
Cells were grown on 18-mm2 glass coverslips and then fixed as described
in the figure legends. The coverslips were washed twice by immersion for
10 s and 5 min in KB buffer (150 mM NaCl, 10 mM Tris-HCl, pH 7.7, 0.1%
Triton X-100, 0.01% BSA [Pentax grade, Miles Laboratories, Inc., Elkhart,
IN, 30% solution]) and then for 5 min in KB without Triton X-100 (KB-).
The excess buffer was removed from the coverslips by gentle shaking and
blotting the edge and back with tissue paper. After this, 75 /Al of the follow-
ing solutions (diluted in KB-) were added to the surface of the coverslip in
the following order. (a) Primary antibodies diluted as follows: Rabbit anti-
PIKA sera 1:1,000; autoimmune anticentromere serum 1:10,000; purified
IgG anti-PCNA autoantibody 1:1,000; mouse monoclonal anti-Sm culture
supernatant 1:10; purified monoclonal IgG anti-CENP-B ascites fluid
1:200; anti-DNA monoclonal culture supernatant 1:2; anti-L protein anti-
bodies 1:250; anti-C, and -CZ monoclonal ascites fluid 4F4 1:5,000; anti-
A, monoclonal culture supernatant 41310 was not diluted. Combinations of
two ofthese antibodies were sometimes used as indicated. (b) Biotinylated
anti-rabbit immunoglobulin antibody (Vector Laboratories, Inc., Burlin-
game, CA) diluted 1:1,000. In experiments such as that shown in Fig. 8, the
anti-PIKA antibodies could be added at this step with the same results. (c)
Streptavidin conjugated with Texas red (Bethesda Research Laboratories,
Gaithersburg, MD), diluted 1:1,000. For experiments where a second anti-
body was used in step a, fluoresceinated anti-human or anti-mousewas also
used at this step at a 1:250 dilution. (d) The DNA binding fluorescent dye
DAPI at 1 14g/ml in KB.
For steps a-c the coverslips were placed in a humid chamber and in-
cubated at 37°C for 30 min. The DAPI treatmentwas done at room tempera-
ture for 5 min. The coverslips were washed between antibody additions for
10 s and 5 min in KB and 5 min in KB- as above. After the last wash, the
coverslips were inverted and mountedwith 25% glycerol in PBS containing
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150 mM Diazabicyclo-octane (Aldrich Chemical Co., Inc., Milwaukee,
WI) used as an antifade agent and sealed at the edges with nail polish.
Molecular Cloning and Production ofAntisera
Autoimmune patient's serum was used to screen a human Xgtll expression
vectorlibrary. cDNAs were isolated and expressed in Escherichia coli from
the 0-galactosidase promoter, or subcloned into pATHII (Spindler et al .,
1984) andexpressed astrpE fusionproteins (Saunders, 1990). These cDNA
clones will be described in detail elsewhere (Saunders, W. S., and W. C.
Earnshaw, manuscript in preparation).
Approximately 20 mg (estimated after Coomassie blue staining by com-
parison with known standards) of trpE fusion protein that contained -13
kD of human polypeptide (38% of total fusion protein) were electropho-
resed on an SDS-polyacrylamide gel. A narrow band containing the fusion
protein was excised and its identity verified by immunoblotting. By compar-
ison to uninduced control cultures the excised band contained >75% of the
total protein as fusion protein. The gel band was soaked twice for 30 min
in water to remove the SDS, ground up to a fine powder in a mortar and
pestle under liquid nitrogen, and transferred to a glass 2.5-ml syringe. 1 ml
of PBS was added, followed by 1 ml of Freund's complete adjuvant (Difco
Laboratories, Inc., Detroit, MI). The mixture was then sonicated (output
setting 4, Branson Sonifier model 200, Branson Sonic Power Co., Danbury,
CT) until a fine emulsion was formed, at which point the solution was too
viscous to pour from the syringe. At day 0, one male rabbit (6 mo old,
Hazleton Research Products, Denver, PA) was injected in multiple loca-
tions: subcutaneously on the back, in the dorsal medial subscapular area,
intramuscularly in the gluteal region, and into the parietal peritoneum
above the abdomen. The animal was boosted with -10 mg ofthe same anti-
gen in incomplete Freund's at30 and 65 d. Blood was drawn passively from
the central ear vein 10 d after the second and third injections and allowed
to clot for 30 min at 37°C. The clot was centrifuged at 4,200 g for 30 min,
the serum drawn off, respun, and the supernatant aliquoted into small
volumes, and stored at -70°C.
Affinity Purification
Affinity purification of specific antibodies from proteins immobilized on
nitrocellulose filters was performed as described (Earnshaw and Roth-
field, 1985).
Cell Synchrony
HeLa cells were grown attached to 150-cm2 flasks for 12-36 h to -80%
confluency. Flasks were preshaken by three vigorous blows with the palm
of the hand, the cells were spun down, and the media was returned to the
flasks. 2 h later the flasks were gently reshaken and the mitotic cells plated
on glass coverslips. At various times after shakeoffthe cells were examined
by immunofluorescence. In some experiments the cells were partly syn-
chronized after shakeoff by being blocked for 9 h with aphidicolin at 2
Ag/ml, washed twice, and released with fresh media. The results with and
without aphidicolin pretreatment were indistinguishable and therefore were
combined in the subsequent analysis. Populations were considered syn-
chronized if>70% ofthe cells had cytoplasmic bridges after shakeoff, and
>85% were positive for PCNA immunostaining during S phase. Only in
some experiments could PIKA inununostaining be readily seen in every
cell. For the cell synchronyexperiments only the cells where PIKA staining
could be clearly seen were counted. Each time point represents 100-600
cells counted during three separate experiments. Examinations were per-
formed blind so thatthe researcherdid not know which time point wasbeing
counted.
Electron Microscopy
Immunoelectron microscopy was performed as described (Cooke et al.,
1990). Briefly, cells were grown on coverslips and fixed in situ with 4%
formaldehyde in Dulbecco's PBS. Treatment with primary antibodies and
subsequent washing was as for immunofluorescence (see above). The cells
were then incubated with goat anti-rabbit IgG conjugated to 1 run gold
(Janssen Life Sciences Products, Piscataway, NJ) diluted 1:100 in KB- for
4 h at room temperature. After washes in KB- and D-PBS, the cells were
fixed in 2% glutaraldehyde with 0.02% tannic acid in D-PBS and silver en-
hanced (IntenSe Silver Enhancement kit; Janssen Life Sciences Products).
The cells examined without antibody label were rinsed briefly with D-PBS
and then fixed with 2% glutaraldehyde in D-PBS plus 2 mg/nil tannic acid
920Figure 1. Discovery ofantisera recognizing a family ofautoantigens
of 23-25 kD. HeLa nuclear proteins were electrophoresed on a
15% SDS-polyacrylamide gel and blotted to nitrocellulose. Verti-
cal strips from the blot were probed with serum from an autoim-
mune patient known to have anticentromere antibodies (lane 1) or
autoantibodies affinity purified from a /3-galactosidase/p23-25 fu-
sion protein (lane 2) . The affinity-purified autoantibodies bind only
to the p23-25 kD proteins . The centromere autoantigens at 17 kD
(CENP-A), 80 kD (CENPB), 140 kD (CENP-C), and 50 kD
(CENP-D) are indicated . Nuclear proteins were screened with
preimmune (lane 3) and immune serum (lane 4) from a rabbit im-
munized with a trpE/p23-25 fusionprotein . The rabbit immune se-
rum, but not the preimmune serum, bound to the p23-25 proteins .
The rabbit immune serum also contained antibodies to a cross-
reacting protein doublet at -77 kD. Rabbit antibodies affinity
purified from the fusion protein immobilized on nitrocellulose
bound only to the p23-25 kD proteins on blots (lane 5) .
for 30 min . The cells were washed in D-PBS, dehydrated, embedded, and
sectioned as described (Cooke et al ., 1990) .
NuclearFermeabilization andEnzyme Treatment
HeLa cells were grown overnight on glass coverslips and treated with KBS
(KB plus 300 mM sucrose with protease inhibitors) at 4°C for 2-5 min .
The protease inhibitor mix included 10 Ulml Trasylol (Mobay Chemical
Corp., Pittsburgh, PA), 10 niM PMSF (Sigma Chemical Co. St . Louis,
MO), and chymostatin, leupeptin, antipain, and pepstatin (CLAP, Sigma
Chemical Co .), each at 1 mg/ml inDMSO. The extracted cells weretreated
with enzyme (or control buffer without enzyme) for 20 min at 4°C (micro-
coccal nuclease) or 20 min at room temperature (RNAse A or DNase I) in
KBS without Triton X-100 (KBS-) . The buffers for enzymatic digestion
were as follows : RNAse ; KBS- , DNase ; KBS- plus 10mM MgC12, micro-
coccal nuclease ; KBS- plus 2 mM CaC12 . The cells were then fixed in
methanol at -20°C and processed for immunofluorescence as described
above, except the cells were washed in KB- only. DNase and RNAse were
purchased from BoehringerMannheimBiochemicals, Indianapolis, IN ; mi-
crococcal nuclease was from Worthington .
Results
Anti-p23-25Antibodies
Among those sera from patients with scleroderma spectrum
disease that recognize centromeres (Moroi et al ., 1980) are
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a small number that also recognize a set ofautoantigens with
molecular masses of -23-25 kD (referred to here as the
p23-25 antigens) (Guldner et al., 1984 ; Earnshaw and
Rothfield, 1985) . These autoantigens can be seen to form a
complex of three to four spots on nonequilibrium two-
dimensional gels (Cox et al ., 1983 ; Saunders,W S ., unpub-
lished observations) . One such serum (Fig . 1, lane 1) was
used to screen ahuman Agtl l cDNA library, and clones ex-
pressing immunopositive fusion proteins were selected as
described elsewhere (Saunders, 1990) . Two sorts of clones
were obtained . The majority consisted ofcDNAs encoding
CENPB, the major centromerec autoantigen (Earnshaw and
Rothfield, 1985) . Others, which provided the starting point
for the experiments described here, encode epitopes present
on the p23-25 antigens (Fig. 1, lane 2) . Autoantibodies
affinity-purified from the fusionprotein recognized the entire
complex of p23-25 antigens, confirming that these antigens
are structurally related (Saunders, W S ., andW C . Earn-
shaw, manuscript in preparation) .
Polyclonal antibodies to the fusion protein from one such
phage clone (that encoded 12.8 kD of human polypeptide)
were raised in a rabbit (see Materials and Methods) . This
immune serum contained antibodies that apparently recog-
nized the entire p23-25 complex of autoantigens (Fig . l, lane
4) . The rabbit immune serum also cross-reacted with several
other proteins . These are apparently unrelated to the p23-25
antigens, as shown by affinity purification ofantibodies from
the rabbit serum using the fusion protein immunogen im-
mobilized on nitrocellulose . Such affinity purified antibodies
bind back only to the p23-25 proteins on blots (Fig . 1, lane
5) and also to the PIKAs as described below (see Fig. 3, J
and K) .
RabbitAntibodiesBind toa NovelSubnuclear Region
We examined the distribution ofthe p23-25 proteins in fixed
cells by indirect immunofluorescence with the rabbit serum .
Antibodies from the immune serum recognized a highly
polymorphic set of substructures within HeLa cell nuclei
(Fig. 2) . We have designated these regions PIKAs .
PIKAs are extremely variable in size and number. They
range in size from a single large roughly spherical region (up
to 5 Am in diameter) in the nuclei ofsome cells to dozens
of smaller punctate foci in others . Discrete antibody binding
regions are not visible in mitotic and earliest G, cells . In-
stead a low level of diffuse staining is seen throughout the
cytoplasm . Preimmune serum from this rabbit recognizes
neither the p23-25 antigens (Fig . 1, lane 3) nor the nuclear
spots in fluorescence (Fig. 2 B, inset) .
Large PIKAs are often quite conspicuous when viewed by
phase-contrast microscopy (Fig . 3) . They can be recognized
as light areas of the nucleus with an irregular, but roughly
spherical, shape . PIKAs often appear to have a distinct
boundary and may have visible internal structure (Fig . 3,
A-C) . They also typically appear to be less phase dense than
the surrounding nucleoplasm (Fig. 3,D and E) . The fluores-
cent immunolabeling within larger PIKAs has a distinct
speckled appearance, suggesting that antibodies may bind to
a cluster of subunits within the PIKA region (Fig . 3 E and
L) . (The speckled appearance is occasionally difficult to see
in photographic prints .) In some cells the PIKAs seem to
break up into smaller subunits, and the distinct boundary
with the rest of the nucleoplasm is lost (see below) .
92 1Figure 2 . Rabbit antibodies to the 23-25 kD proteins detect a polymorphic population of structures within HeLa cell nuclei . HeLa cells
were grown on coverslips, fixed in 100% methanol at -20°C, and screened by indirect immunofluorescence using serum from a rabbit
immunized with the p23-25 fusion protein . This antibody recognizes regions within the nucleus of most cells . The size and number of
the stained structures varied greatly between different cells . Phase-contrast (A) and fluorescence (B) images are shown . Preimmune serum
was not immunoreactive (inset in B shows a field containing -25 cells) . m, mitotic cell . Bars : (A and B) 20 Am ; (inset) 100 Am .
We have also observed other "phase-light" regions of the
nucleus that do not react with the anti-PIKA antibodies .
These may represent additional nuclear domains similar
to the PIKAs, but lacking the p23-25 antigens (Fig . 3, F
and G) .
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PIKAsAre Present in a Variety ofCell Types
PIKAs appear to be fundamental nuclear features present in
a variety ofhuman cell types . They are not specialized fea-
tures of transformed cells . Epithelial (HeLa), erythroid
922Figure 3 . Gallery showing several important aspects of PIKA morphology. (A-C) The PIKA is often directly visible by phase-contrast
microscopy. The domains recognized by antibody appear less dense than the surrounding nucleoplasm under phase contrast. (F and G)
It is possible to observe phase-light regions of the nucleus that do not react with the anti-PIKA antibodies . In theexample shown, a single
PIKA is seen in this HeLa cell (F, arrowhead) . Another phase-light region of the nucleoplasm was not immunoreactive (F, arrowhead,
0) . (H and I) Primary human fibroblast nuclei contain PIKAs of morphology similar to those seen in HeLa cells . (J-L) Affinity-purified
antibodies specific for the 23-25 kD antigens bind to PIKAs. In this case, antibodies were affinity purified from a bacterial fusion protein
(see Fig. 1, lane S) . The granular substructure of the PIKA is particularly visible in L. A, D, F, H, and J show phase-contrast images .
B, E, G, I, andLshow anti-PIKA fluorescence. Phaseand fluorescence images are superimposed inCDNA staining with DAPI is shown
inK . Except forHand I, cells were fixed in 100% methanol at -20°C . The cell inHand1was fixed in 3% formaldehyde in PBS . Bars,
10 Jim .
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924(K-562), and two primary diploidhuman fibroblast cell lines
were tested by immunofluorescence with the anti-PIKA se-
rum . PIKAs with a similar distribution in size, shape, and
number were observed in all these cell types . An example
of such staining of a primary fibroblast is shown in Fig . 3,
H and I . We have not observed specific staining using this
serum on cells of other species (including Indian muntjac,
BHK, and pig kidney epithelial (LLC-PK) cells although
similar phase-light areas have been observed within the cell
nuclei .
Anti-p23-25AntibodiesBind to thePIKAs
Anti-p23-25 antibodies affinity purified from several differ-
ent substrates bound to PIKAs in a manner qualitatively in-
distinguishable from that of whole serum . The substrates
used for affinity purification included both /3-galactosidase
and tryptophan synthetase (trp E) p23-25 fusion proteins, as
well as gel-purified cellular p23-25 proteins from HeLa
cells (Fig . 3, J and K) . When affinity purification experi-
ments were performed with four other unrelated bacterial
and human proteins no specific staining was observed
(results not shown) . These results demonstrate convincingly
that antibodies that bound to PIKAs by immunofluorescence
also bound to the p23-25 proteins on blots .
The Ultrastructure of thePIKAs
The use ofa recently developed procedure for immunolocali-
zation of nuclear antigens with ultrasmall colloidal gold
probes (Cooke et al ., 1990) permitted us to examine the
Figure 5. PIKA staining depends on the in-
tegrity of the DNA . HeLa cells were per-
meabilized with a buffer containing Triton
X-100 (see Materials and Methods) and
treated with micrococcal nuclease before
immunofluorescence. (A) Nuclei were still
structurally intact as determined by phase-
contrast microscopy ; (B) DAPI fluorescence
was slightly reduced as expected . (C) Cen-
tromere immunolabeling was still detected
after nucleasetreatment . (D) The anti-PIKA
staining was greatly reduced or absent (D)
from nuclease-treated cells . Cells were fixed
in 100% methanol at -20°C . Bar, 20 /Am .
structure of the PIKAs by electron microscopy. This proce-
dure revealed that PIKAs have lower electron density than
the surrounding nucleoplasm and are traversed by fibrous
material with an average diameter of 11-17 nm (Fig . 4 A) .
The rabbit antibody often bound to these fibers at points of
intersection . Nonuniform binding may be responsible for the
speckled appearance of thePIKAs observed by immunofluo-
rescence (Fig . 3 E) . The PIKAs were occasionally found
near regions of heterochromatin or nucleoli .
Low levels of antibody binding to the cytoplasm and to the
rest of the nucleus were also observed, suggesting that the
antibody may also react with a diffuse component . No sig-
nificantbinding was seen withpreimmune serum (results not
shown) . Quantitative analysis showed the density of the gold
label with the immune serum was >8 times higher in PIKAs
than in the rest of the nucleoplasm ; >5 times higher than in
the cytoplasm ; and >38 times higher than in the nucleolus .
We do notknow whether the low level ofbackground binding
in the rest ofthe nucleus was due to the presence ofdispersed
PIKA antigens or to nonspecific binding of the gold probes .
When cells are fixed in glutaraldehyde and embedded
without antibody treatment, it is possible to identify nuclear
regions that resemble PIKAs with regard to size, shape, and
distribution . We feel it likely that this is the appearance of
the PIKAs in optimally fixed cells (Fig . 4B) . The enhanced
specimen preservation afforded by glutaraldehyde fixation
permits us to observe that these regions are apparently de-
void of interchromatin granules, which are nearly ubiquitous
in the nucleoplasm (Fakan, 1986) . The absence of inter-
chromatin granules could account for the apparent lower
Figure 4. Ultrastructural characterization of the PIKA . (A) PIKAs were detected by preembedding immunoelectron microscopy with rabbit
anti-PIKA antibodies . Immunogold label was detected in nuclear regions with lower apparent density than the surrounding nucleoplasm .
Fibers traversing the labeled regions appeared to be the sites of antibody binding . Lower levels of immunolabeling could also be detected
in other areas ofthe nucleus, possibly due to a background diffuse distribution of the antigen . (B) HeLa cells were fixed in glutaraldehyde
without immunolabeling (see Materials and Methods) and examined for the presence of PIKA-like regions . Putative PIKAs were visible
as regions of low electron density in the nucleoplasm (arrows) . Interchromatin granules (IG, circles) were not detected in these regions.
Densely staining areas on either side of the photograph are nucleoli . Bar, 1 um .
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925Figure 6. The morphology ofthe PIKAs changes as a result ofcell
cycle phase . The frequency of six different types ofPIKA structure
was determined for synchronized cells at various times after mitotic
shake off. Graphs showing the frequency of the PIKAs in synchro-
nized populations are given . The frequency of each type of PIKA
changed gradually during the cell cycle . The larger type 1 and type
2 PIKAs were present only in G, and early S phase. The smaller
types were the mostcommon form later in the cellcycle . These data
suggest a gradual shift to smaller and dispersed PIKAs during the
cell cycle .
density of the PIKAs when compared to the rest of the
nucleoplasm .
PIKAsRequires Intact DNA to Maintain
Antigenic Identity
To begin to examine the relationship between PIKAs and
DNA, we tested whether enzymatic digestion of the DNA
had any effect on PIKA morphology in permeabilized HeLa
cells . Cells were permeabilized with a buffer containing
0.5% Triton X-100 and treated with micrococcal nuclease or
DNase I before antibody incubation (Fig. 5) . These mild
digestion conditions reduced, but did not abolish, DNA
staining with DAPI (Fig . 5 B) . In contrast, the antibody
binding to the PIKAs was greatly reduced or absent after
nuclease treatment (Fig . 5 D) . Abolition ofPIKA staining re-
quired active enzyme, for no reduction of antibody binding
was observed if cells were pretreated with buffer minus
nuclease or with micrococcal nuclease without the required
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calcium . Not all nuclear substructure was eliminated by the
nuclease treatment as shown by phase-contrast examination
andby the persistence of centromere staining (Fig . 5 C) . Al-
though this experiment should not be taken as proof that
DNA is an integral component of the PIKA, the results sug-
gest that PIKAs are associated with DNA at some level. In
contrast, RNA integrity is apparently not required to main-
tain the structure of the PIKAs. PIKA staining was
unaffected by treatment with 50 p,g/mlRNÀseA (results not
shown) .
We examined the distribution ofDNA in the nucleus rela-
tive to the PIKAs by immunofluorescence and confocal mi-
croscopy. Anti-DNA antibodies bound throughout the nu-
cleus with variable intensity . The anti-PIKA antibodies
bound reproducibly to regions of the nucleus with relatively
less anti-DNAantibody binding (Fig . 3,Kand L) . This result
was seen regardless ofthe order in which the anti-PIKA and
anti-DNA antibodies were added . This suggests that PIKAs




PIKAs undergo a striking change in appearance as HeLa
cells traverse the cell cycle . To quantify this phenomena, the
morphology of thePIKAs was classified into six categories,
and the percentage ofcells with each category ofPIKA stain-
ing was determined for synchronized cells at different times
after mitosis (Fig . 6) . The large type 1 and type 2 structures
were detected only during G, and early S phase . As the cy-
cle progressed, the PIKAs gradually became smaller and
more numerous, as if the larger PIKAs disassociated into
smaller subunits. By late S phase, nearly all cells in the syn-
chronized population had a dispersed punctate nuclear stain-
ing (type 6) . Micrographs of cells with representative PIKA
types are shown in Fig . 7 .
Relationship to OtherNuclear Components
The PIKAs appear to be independent from sites of DNA
replication and/or concentrations of PCNA, a cofactor of
DNA polymerase 6 (Bravo et al ., 1987 ; Prelich et al ., 1987) .
HeLa cells were screened simultaneously with anti-PIKA
antibodies and anti-PCNA antibodies . The PIKA staining
appeared to be independent of the position of PCNA (Fig .
8, A and B) . Since the PIKAs were also detected when no
DNA synthesis is occurring in the cell (as defined by the ab-
sence of PCNA immunofluorescence and in synchronized
cells known to be in G,), we believe the structural differen-
tiation of this nuclear region is not directly due to DNA
replication .
Similarly, we examined the distribution of RNA polymer-
ase II in HeLa nuclei relative to the PIKAs, Polymerase II
was found to be distributed throughout the nucleus, includ-
ing the PIKAs . However, it showed no tendency to be con-
centrated in the PIKA regions (results not shown) .
The speckled PIKA staining observed during late S and
G 2 phases of the cell cycle resembles that of centromeres
(Moroi et al ., 1980) . However, centromeres and PIKAs are
distinct entities . The speckles stained with the anti-PIKA an-
tiserum do not colocalize with antibodies to the centromere-
associated CENP-B antigen (Fig . 8, C and D) . The confocal
926Figure 7 . Examples of the six classes of PIKA morphology. During mitosis (M) and very early G,, only a diffuse cytoplasmic staining
canbe detected . Numbers 1-6 refer to the morphological classes presented in Fig. 6 . Cells were fixed in 100% methanol at -20°C. Bar,
5 gm .
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Figure 8 . PIKAs do not correspond to regions of ongo-
ing replication, centromeres, or concentrations of
snRNP antigens . Anti-PIKA serum immunofluores-
cence is shown in A, C E, andG . B shows regions of
ongoingDNAreplication detected with anti-PCNA .D
andFshow the location of the centromeric heterochro-
matin, detected with monoclonal antibody to CENP-B
(Earnshaw et al ., 1987) . (E andFwere obtained with
the laser scanning confocal microscope.)Hshows pre-
sumed regions ofRNA splicing, detected with mono-
clonal antibody to the Sm antigens . The arrowhead in
H shows PIKA region. PCNA, centromeres, and SM
antigens are all apparentlyabsent from thePIKAs . Cells
were fixed in 100% methanol at -20°C . Bar, 10 Am .Figure 9 Exclusion of the hnRNP C, and C2 proteins from the
PICA regions . A shows the pattern of binding of anti-PICA anti-
body to HeLa nuclei . B shows the binding ofantibody recognizing
the hnRNP C, and C 2 proteins to the same nucleus . Arrows indi-
cate the PICA region . C, and C2 proteins are located throughout
much of the nucleoplasm but are absent from the PICA regions.
Other regions ofdecreased antibody bindingcommon to bothpanels
are nucleoli . To emphasize the absence of the hnRNP C, and C2
proteins from the PICA, A was exposed for considerably longer
than the other figures showing PICA staining . Cells were fixed in
100% methanol at -20°C followed by acetone at -20°C for 30 s .
microscopy images ofFig . 8,E and F, shows the independent
distribution ofPIKAs and centromeres particularly clearly.
PIKAs are apparently not associated with proteins in-
volved in RNA processing or packaging . The Sm. antigens
(involved in RNA processing ; Lerner et al ., 1981) (Fig . 8,
G and H) and the ImRNP C, and C2 proteins (Dreyfuss,
1986 ; Pinol-Roma et al ., 1989) (Fig . 9) were all excluded
from thePICA regions. Similar results were observed for the
hnRNP A, and L proteins (results not shown) . These re-
sults were seen regardless of the order in which the anti-
bodies were added (data not shown) . The observed exclusion
of these nuclear RNA-associated proteins was true for both
the diffuse and concentrated forms of Sm (Nyman et al .,
1986) and the ImRNP antigens (Pinol-Roma et al ., 1989) .
These results suggest that bothsnRNP andhnRNP are found
only rarely (or not at all) in the large PIKAs .




PIKAs are large, roughly spherical nuclear regions that were
first visualized after staining with a specific antibody, but
that are also visible by phase-contrast and electron micros-
copy. Two arguments suggest that PIKAs represent a fun-
damental structural feature ofthe cell nucleus. First, they are
visible both by phase-contrast and immunofluorescence mi-
croscopy after a variety of preparative procedures, including
the use of three different fixatives (methanol, formaldehyde,
or glutaraldehyde), as well as different wash and incubation
buffers . Second, PIKAs were visible in all human cell lines
tested (both transformed and primary cultures) . This sug-
gests that PIKAs are not a consequence of specialization
within a particular cell type . PIKAs may have gone undis-
covered before the development of the antibodies discussed
in this paper because they have a lower density than the sur-
rounding nucleoplasm .
We have thus far been unable to demonstrate PICA-like
nuclear staining innonhuman cell lines . This may be a con-
sequence of species specificity of the antibodies, since phase-
light regions with a morphology similar to PIKAs could be
visualized in these cells .
When nuclei are extracted with various combinations of
detergent, nucleases, and high salt or chaotropic agents, the
residual insoluble material is referred to as the nuclear ma-
trix (Berezney and Coffey, 1977; Berezney, 1984 ; Kaufmann
et al., 1986) . The view of many researchers in this field is
that the insoluble proteins of the nuclear matrix comprise a
structural scaffolding for the nucleoplasm (Berezney, 1984 ;
Vogelstein et al ., 1985) . PIKAs are sensitive to nuclease
treatment in permeabilized cells and are therefore not part
of the nuclear matrix .
Composition ofthe PIKAs
Rabbit antibodies that bind to the PIKAs also bind to the
p23-25 proteins, suggesting that these proteins are concen-
trated within this nuclear compartment. However, human
autoantibodies that also bind to these proteins on blots do not
react with PIKAs by immunofluorescence . This is consistent
with the results of earlier studies which failed to detect any
significant binding to cultured cells with affinity-purified
anti-p23-25 autoantibodies (Guldner et al., 1984 ; Earn-
shaw and Rothfield, 1985) . We have demonstrated elsewhere
that the human anti-p23-25 autoantibodies bind to a limited
region of<58 amino acids on these proteins, and possibly
to a single epitope within this region (Saunders, W S ., and
W C . Earnshaw, manuscript in preparation) . It is therefore
possiblethatthe portionofthe p23-25 proteins recognized by
the autoantibodies is not accessible in the intact cell . While
we cannot exclude the possibility that the anti-PICA anti-
bodies may cross-react in situ with an antigen other than the
p23-25 proteins, it is important to note that affinity-purified
rabbit antibodies that detect only the p23-25 antigens on im-
munoblots exhibit PICA fluorescence identical to that seen
with whole serum (Fig . 3, J and K) .
Enzyme digestion experiments suggest that DNA is re-
quired for the structural integrity of the PICA . PIKAs are
928no longer detected by immunofluorescence aftertreatment of
permeabilized cells with micrococcal nuclease or DNase I.
Immunoelectron microscopy shows that the antigens are
localized on -15-run-diam fibers that traverse a less dense
region of the nucleoplasm. These fibers may be chromatin
in an extended configuration . The simplest interpretation of
these results is that DNA is a structural component of the
PIKAs, although other explanations are also possible.
Structure ofthePIKAsChangesDramatically during
theCell Cycle
When logarithmic cultures are stained with anti-PIKA se-
rum, several different patterns of nuclear staining are ob-
served. This variability in staining is correlated with the cell
cycle phase. PIKAs of G, or S phase cells frequently com-
prise one or a very few large nuclear domains, each ofwhich
may be up to 5 gm in diameter. The presence of a discrete
substructure within these domains is suggested by the speck-
led pattern of antibody binding. One interpretation of this
morphology is that the larger PIKAs are aggregates of
smaller subunits. This is consistent with the changes in
PIKA structure seen during the cell cycle. As the PIKAs be-
come progressively smaller and more dispersed, the larger
structures apparently break apart into smaller clusters and
eventually into single foci . These foci are about the size of
centromeres stained with antibodies specific for CENP-B
(Earnshaw et al., 1987).
Evidence from several laboratories suggests that inter-
phase chromosomes occupy nonoverlapping domains within
the nucleus (Manuelidis and Borden, 1988; Pinkel et al.,
1988 ; Haafand Schmid, 1991). The size ofthe larger PIKAs
approaches the size of chromosomal domains ofhumanlym-
phocytes (Pinkel et al ., 1988) and it is possible that the large
PIKAs observed during the first half of the cell cycle repre-
sent such chromosomal domains. This might explain the de-
pendence of the immunofluorescence on intact DNA . Fur-
thermore, if the PIKA proteins are associated with DNA,
they may then serve as markers for the movement ofunderly-
ing specific DNA sequences. The dramatic changes in PIKA
morphology during late G, and S phases may be indicative
of structural rearrangements that occur in the nucleus at this
time. Examination ofthe distribution ofcentromere antigens
as a function ofcell cycle phase supports the notion that chro-
mosomal domains undergo significant movements as a func-
tion of cell cycle phase (for review see Haaf and Schmid,
1991).
Pbssible FunctionsofthePIKAsin Cells
The observation that PIKAscorrespond to less dense regions
of the nucleoplasm suggests that the antigens are associated
with euchromatin. This, in turn, could be consistent with a
role for the PIKA proteins in either transcription or some
facet of RNA processing or storage. We believe this to be
unlikely, however.
There is increasing evidence for higher-order organization
of RNA transcription and processing within the nucleus.
This was first seen for RNA processing as a result of the
availability of autoantibodies specific for components of the
processingmachinery. Three-dimensional reconstruction of
anti-Sm-labeled cells from electron micrographs revealed
Saunders et al. Compartmentalization within the Nucleus
that snRNP antigens are distributed in a reticular network
occupying -18% of the nuclear volume (Spector, 1990) .
Smaller specialized areas of apparent spliceosome assembly
(identified using a monoclonal antibody to an antigen desig-
nated SC-35) have also been identified (Fu and Maniatis,
1990). Discrete concentrations ofhnRNP have been demon-
strated with antibodies to the hnRNP-associated L protein
(Pinol-Roma et al., 1989) . In addition to being distributed
throughout much of the nucleus, a subfraction ofthis protein
was found to be concentrated in 1-3 large regions in all HeLa
nuclei.
More recently, it has been shown that polyadenylated RNA
is concentrated in "20-40 discrete foci within the nucleus,
which have been referred to as "transcript domains" (Carter,
K., and J. Lawrence, personal communication). Because the
transcript domains also correspond to major foci of Sm anti-
body staining, it is possible that significant levels of nuclear
RNA processing also occur within these compartments.
Double staining for PIKAs and for Sm and hnRNP anti-
gens reveals that the latter antigens are excluded from
PIKAs. Thus, PIKAs are distinct from the transcript do-
mains, and are unlikely to represent sitesof RNA processing
or storage. They are also unlikely to correspond to major
loci of polymerase II transcription, since while RNA poly-
merase II does occur within PIKAs, this may simply reflect
the distribution of the enzyme throughout the nucleus.
Specific antibodies show no evidence for concentration of
polymerase II in the PIKAs. Furthermore, we have failed to
notice any change in structure of the larger PIKAs after pro-
longed exposure to the transcriptional inhibitor ei-amanitin
(Lindell et al., 1970; results not shown).
Together, these observations suggest that PIKAs represent
areas of euchromatin that are neither sites of active RNA
transcription, storage, or processing. The functional sig-
nificance of the PIKAs thus remains unknown.
Compartmentalization within the Nucleus
The observations that some nuclear proteins (the p23-25 an-
tigens) are specifically concentrated in the PIKA while
others (snRNP- and hnRNP-associated proteins) are appar-
ently excluded from it suggest that the PIKA is a distinct nu-
clear compartment. It is tempting to speculate that this
segregation ofprotein antigens may be reflectiveofa broader
pattern of functional segregation within the nucleus as well.
Until very recently, the concept that the nucleoplasm
might be subdividedinto discrete compartments was consid-
ered hypothetical, and was little supported by direct observa-
tion. The only nuclear substructures, other than the nucleo-
lus, that had been described had been observed solely by
electron microscopy and nothing was knownabouttheir con-
stituents. This has now changed, however, and three well-
documented examples of mammalian nuclear Compartmen-
talization have been reported in the recent literature.
The nuclear substructures that most resemble PIKAs are
termed coiled bodies. These are spherical objects, 0.3-0.5
gm in diameter, that were initially observed using a his-
tochemical stain for RNA in the electron microscope (Mon-
neron and Bernhard, 1969) . Coiled bodies contain twisted
fibrils (presumably proteinaceous) that are insensitive to
DNase I treatment. A specific protein component of coiled
bodies has recently been identified using a human autoanti-
929body, in a study that reveals both significant similarities and
differences between coiled bodies and the PIKA (Raska et
al., 1991). The two resemble one another in four ways: (1)
both show a frequent proximity to the nucleolus; (2) both
contain a lower concentration of DNA than the surrounding
nucleoplasm; (3) both are devoid of hnRNP L protein; and
(4) both appear to lack interchromatin granules. Despite
these similarities, PIKAs and coiled bodies show several
differences. The size of the marker antigens is different (80
kD for coiled bodies and 23-25 kD for PIKAs), although this
does not exclude the presence of both antigens in a single
structure. More significantly, the number and size of the two
structures differ. Antibody staining failed to reveal more
than eight coiled bodies per nucleus (Raska et al., 1991),
while a significantly larger number of PIKA foci is seen in
the latter part ofthe cell cycle. In addition, the largest PIKAs
(N5 gm) are 5-10-fold larger than the largest coiled bodies.
Finally, the appearance ofthe two structures (as observed by
electron microscopy) differs. Coiled bodies are typically
more dense than the surrounding nucleoplasm and are often
surrounded by a capsule (Monneron and Bernhard, 1969) .
In contrast, the PIKA appears to be less dense than the sur-
rounding nucleoplasm and lacks a defined capsule. We con-
clude that coiled bodies and PIKAs are most likely to be dis-
tinct entities within the nucleoplasm.
PIKAs show less resemblance to nuclear bodies, which
are spherical, encapsulated structures that apparently bud off
of the nucleolus and may contain nascent ribosomal RNA
(Vagner-Capodano et al., 1982) . The structure of nuclear
bodies varies considerably: both the granular and fibrillar
components ofthe nucleolus can be seen in different propor-
tions for different nuclear bodies (Dupuy-Coin and Bou-
teille, 1972). Autoantibodies that recognize nuclear bodies
have recently been described (Fusconi et al., 1991). These
recognize an antigen of either 78-92 or 96-100 kD (it was
not possible to distinguish between the two) . Between 5 and
15 nuclear bodies couldbe detected per cell, and in all cir-
cumstances these were significantly smaller than the large
PIKAs. Because nuclear bodies look even less like PIKAsby
electron microscopy than do coiled bodies, we again con-
clude that the two are likely to be distinct structures.
A third nuclear substructure more similar to the PIKA was
identifiedusing an autoantibody that reacts with a 55-kD nu-
clear protein (Ascoli and Maul, 1991). This antibody recog-
nizes a scattering of "nuclear dots" in growing cells from a
variety of organisms. These dots resemble the PIKAs as they
appear in the laterparts of the cell cycle. Like the PIKA, nu-
clear dots are also apparently not associated with RNP pro-
tein domains or centromeres. However, they differ from the
PIKA in two important regards. First, at no time in the cell
cycle does the size of the nuclear dots approach that of the
PIKA during G, phase. Second, the fluorescence of nuclear
dots is unchanged after treatment of the nuclei with DNase
1. Thus, the nuclear dots apparently comprise yet another
class of nuclear domains that is distinct from the PIKA.
Together, these recent results are consistent with an
emerging view ofthe structure of the nucleus. This view sug-
gests that the nucleoplasm is, at least in part, differentiated
into distinct structural domains. Some of these domains are
visible by phase-contrast microscopy alone. Nucleoli are a
conspicuous example of this type of compartmentalization.
The PIKAs, whilevisible, are less striking under phase con-
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trast and required the development of specific antibodies for
their presence to be convincingly demonstrated. Careful ex-
amination of fixed cells by phase contrast reveals the pres-
ence of other large, structurally distinct "phase-light" nu-
clear regions that do not bind the anti-p23-25 antibodies.
We suspect that these representother specialized nuclear do-
mains, and suggest that as antibodies for other nucleoplas-
mic proteins are developed, markers for these regions may
become available as well.
Conclusions
These experiments, together with previous work describing
the hnRNP L (Pinol-Roma et al., 1989), SC-35 (Fu and
Maniatis, 1990), and "nuclear dot" antigens (Ascoli and
Maul, 1991) support an emerging view of the nucleus as be-
ing compartmentalized into multiple discrete domains that
can often be identified only using antibody probes. The most
striking observation presented here is that the PIKAs (like
nucleoli) undergo dramatic morphological alterations as
cells traverse the cell cycle. It will be interesting to note
whether other domains are static, or whether, like the
PIKAs, they undergo structural rearrangements as a function
of cell cycle phase.
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